CH311614A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).Info
- Publication number
- CH311614A CH311614A CH311614DA CH311614A CH 311614 A CH311614 A CH 311614A CH 311614D A CH311614D A CH 311614DA CH 311614 A CH311614 A CH 311614A
- Authority
- CH
- Switzerland
- Prior art keywords
- anilide
- methyl
- benzylamine
- chloro
- halogen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 title claims description 7
- 229930195729 fatty acid Natural products 0.000 title claims description 7
- 239000000194 fatty acid Substances 0.000 title claims description 7
- 150000004665 fatty acids Chemical class 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims description 30
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000003931 anilides Chemical class 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 239000003589 local anesthetic agent Substances 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- WFNLHDJJZSJARK-UHFFFAOYSA-N 2-chloro-6-methylaniline Chemical compound CC1=CC=CC(Cl)=C1N WFNLHDJJZSJARK-UHFFFAOYSA-N 0.000 claims description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 2
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 239000013067 intermediate product Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids).
Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), welehes dadurch gekennzeich- net ist, dass man eine Verbindung der Formel
EMI1.1
in weleher X einen reaktionsfähigen, während der Reaktion sieh abspaltenden Rest, bedeutet, mit Benzylamin umsetzt.
Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsul fonyloxy-oder Arylsulfonyloxygruppe, bestehen. Der Austausch der Gruppe X gegen den Benzylaminrest erfolgt z. B. durch einfaches Erwärmen mit Benzylamin gegebenenfalls in Gegenwart eines basisch reagierenden Konden- sationsmittels oder von Benzylamin im Überschuss. Das Benzylaminoacet- (2-ehlor-6-methyl- anilid) ist ein farbloses 61. Das Hydroehlorid der Base sehmilzt bei 237-238 unter Zersetzung.
Das neue Anilid soll als Lokalanästhetikmn und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.
Beispiel:
36 Gewichtsteile Chloracet- (2-chlor-6-me- thyl-anilid) (gewonnen durch Umsetzen von 2 Chlor-6-methyl-anilin mit Chloracetylehlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 80 Gewichtsteilen Äthanol suspendiert und mit 54 Gewichtsteilen Benzylamin versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Reaktions- gemisches geht in Losung. Nun wird während 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei Siedetemperatur. Mit Wasserdampf wird hiera. uf der Alkohol und das überschüssige Benzylamin abgeblasen und nach dem Erkalten das zurückbleibende 0l in Äther aufgenommen.
Nach dem Trocknen der ätherischen Losung und Verjagen des Lo sungsmittels verbleibt ein öl, das durch Uber- führung in das Hydrochlorid gereinigt wird.
Man erhält 40 Gewiehtsteile reines Benzylamino-acet- (2-chlor-6-methyl-anilid). Die Umsetzung mit Benzylamin kann auch in Benzol stattfinden.
PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), dadurch gekennzeichnet, dass man eine Verbindung der Formel
EMI1.2
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
The subject of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula
EMI1.1
in which X is a reactive radical which is split off during the reaction and is reacted with benzylamine.
The radical X can be in a halogen atom or any other reactive substituent suitable for replacement with the basic radical, such as. B. an alkyl sulfonyloxy or aryl sulfonyloxy group exist. The exchange of group X against the benzylamine radical takes place z. B. by simply heating with benzylamine, possibly in the presence of a basic condensing agent or benzylamine in excess. Benzylaminoacet- (2-chloro-6-methyl anilide) is a colorless 61. The hydrochloride of the base melts at 237-238 with decomposition.
The new anilide is said to be used as a local anesthetic and as an intermediate for the production of other derivatives.
Example:
36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are suspended in 80 parts by weight of ethanol and mixed with 54 parts by weight of benzylamine. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at boiling temperature. With steam here a. The alcohol and the excess benzylamine are blown off and after cooling the remaining oil is taken up in ether.
After the ethereal solution has dried and the solvent has been driven off, an oil remains, which is purified by being converted into the hydrochloride.
40 parts by weight of pure benzylamino-acet- (2-chloro-6-methyl-anilide) are obtained. The reaction with benzylamine can also take place in benzene.
PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula
EMI1.2
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH311614T | 1952-02-25 | ||
| CH307799T | 1952-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH311614A true CH311614A (en) | 1955-11-30 |
Family
ID=25735347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH311614D CH311614A (en) | 1952-02-25 | 1952-02-25 | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH311614A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
| US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
-
1952
- 1952-02-25 CH CH311614D patent/CH311614A/en unknown
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11643404B2 (en) | 2019-03-11 | 2023-05-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
| US11603355B2 (en) | 2019-03-11 | 2023-03-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12195428B2 (en) | 2019-03-11 | 2025-01-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
| US11512058B2 (en) | 2019-03-11 | 2022-11-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11696912B2 (en) | 2019-11-06 | 2023-07-11 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12303496B2 (en) | 2019-11-06 | 2025-05-20 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US12162851B2 (en) | 2020-03-11 | 2024-12-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH311614A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311613A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311606A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311608A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311607A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311612A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311609A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311610A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311615A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311611A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311603A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311619A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311644A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311632A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311639A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311624A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311629A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311630A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311637A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311642A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311620A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311631A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311604A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311605A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
| CH311617A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |